Utah Medical Products Q3 EPS $1.025 Down From $1.08 YoY, Sales $10.01M Down From $12.51M YoY
Portfolio Pulse from Benzinga Newsdesk
Utah Medical Products reported a decrease in Q3 earnings per share and sales compared to the same period last year. EPS fell by 5.09% to $1.02, and sales dropped by 19.99% to $10.01 million.
October 29, 2024 | 1:28 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Utah Medical Products reported a decline in Q3 earnings per share and sales. EPS decreased by 5.09% to $1.02, and sales fell by 19.99% to $10.01 million compared to the same period last year.
The decrease in both EPS and sales indicates a weaker financial performance compared to the previous year, which is likely to negatively impact the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100